BetterLife Pharma (BETRF) Interest Coverage Ratio (2015 - 2022)
BetterLife Pharma (BETRF) posted quarterly Interest Coverage Ratio of 1789.27 for Q2 2022, up 1389.6% year-over-year from 120.12 in Q2 2021, and up 4655.93% quarter-over-quarter from 39.27 in Q1 2022.
BetterLife Pharma (BETRF) Interest Coverage Ratio (2015 - 2022) Analysis & Trends
BetterLife Pharma's Interest Coverage Ratio history runs 8 years deep, the most recent figure standing at 1789.27 for Q2 2022.
- In Q2 2022, Interest Coverage Ratio rose 1389.6% year-over-year to 1789.27; the TTM figure through Apr 2022 stood at 183.03 (down 106.25% YoY), while the FY2026 annual figure was 10.41, up 65.62% from the prior year.
- Interest Coverage Ratio for Q2 2022 stood at 1789.27, up from 39.27 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 26853.37 in Q4 2020, with the low at 3353.88 in Q1 2021.
- The 5-year median for Interest Coverage Ratio is 0.42 (2018), against an average of 2134.77.
- The sharpest annual moves came in 2021 and 2022: Interest Coverage Ratio tumbled 99.14% in 2021, then surged 1389.6% in 2022.
- BetterLife Pharma's Interest Coverage Ratio stood at 10.47 in 2018, then surged by 85.75% to 1.49 in 2019, then surged by 1799459.09% to 26853.37 in 2020, then sank by 99.14% to 231.98 in 2021, then soared by 671.32% to 1789.27 in 2022.
- Business Quant data shows BETRF's Interest Coverage Ratio at 1789.27 in Q2 2022, 39.27 in Q1 2022, and 231.98 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | BetterLife Pharma | 40.15 Mn | 42.53 Mn | - | 51.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2022 | 1,789.27 |
| Jan 31, 2022 | -39.27 |
| Oct 31, 2021 | 231.98 |
| Jul 31, 2021 | 235.19 |
| Apr 30, 2021 | 120.12 |
| Jan 31, 2021 | -3,353.88 |
| Oct 31, 2020 | 26,853.37 |
| Jul 31, 2020 | 1,930.03 |
| Apr 30, 2019 | -1.49 |
| Oct 31, 2018 | -10.47 |
| Jul 31, 2018 | -1.64 |
| Apr 30, 2018 | -1.57 |
| Jan 31, 2018 | 0.42 |
| Jul 31, 2017 | -29.74 |
| Apr 30, 2017 | -32.49 |
| Jan 31, 2017 | -102.14 |
| Oct 31, 2016 | -191.11 |
| Jan 31, 2016 | 4.08 |
| Oct 31, 2015 | 0.45 |
| Apr 30, 2015 | -4.26 |